Tengjun Biotechnology Corp
Tengjun Biotechnology Corp., through its subsidiaries, engages in producing, packaging, distributing, and marketing featured dandelion teas and water purifiers in the People's Republic of China. It offers black and green dandelion teas; and household water purifiers. The company was founded in 2010 and is headquartered in Jining, China.
Tengjun Biotechnology Corp (TJBH) - Total Liabilities
Latest total liabilities as of June 2023: $423.70 Million USD
Based on the latest financial reports, Tengjun Biotechnology Corp (TJBH) has total liabilities worth $423.70 Million USD as of June 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Tengjun Biotechnology Corp - Total Liabilities Trend (2015–2022)
This chart illustrates how Tengjun Biotechnology Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Tengjun Biotechnology Corp Competitors by Total Liabilities
The table below lists competitors of Tengjun Biotechnology Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Heritage Foods Limited
NSE:HERITGFOOD
|
India | ₹6.12 Billion |
|
Finwise Bancorp
NASDAQ:FINW
|
USA | $783.94 Million |
|
Shanghai Smart Control Co. Ltd.
SHE:001266
|
China | CN¥757.87 Million |
|
Jaeyoung Solutec Co. Ltd
KQ:049630
|
Korea | ₩123.61 Billion |
|
OP Bancorp
NASDAQ:OPBK
|
USA | $2.42 Billion |
|
Awfis Space Solutions Ltd
NSE:AWFIS
|
India | ₹21.96 Billion |
|
Commerce.com, Inc.
NASDAQ:CMRC
|
USA | $266.63 Million |
Liability Composition Analysis (2015–2022)
This chart breaks down Tengjun Biotechnology Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 28.52 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.97 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tengjun Biotechnology Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tengjun Biotechnology Corp (2015–2022)
The table below shows the annual total liabilities of Tengjun Biotechnology Corp from 2015 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $43.66 Million | +167.57% |
| 2021-12-31 | $16.32 Million | +5473.53% |
| 2020-12-31 | $292.74K | +3.10% |
| 2019-12-31 | $283.94K | +13.96% |
| 2018-12-31 | $249.15K | +13.98% |
| 2017-12-31 | $218.58K | +5.89% |
| 2016-12-31 | $206.43K | +30.58% |
| 2015-12-31 | $158.09K | -- |